Germany | BCH-RA-DE-101196 | Risk Assessment generated by a regulatory process | Biosafety Clearing-House

Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-DE-101196-4   |   PDF   |   Print   |  
published: 25 May 2010 last updated: 11 Jun 2020
General Information
6786-01-0198 (adv. 42010-0198); Summary of the risk assessment of a deliberate release (field trial) of genetically modified maize (Zea mays) GA21 (MON-00021-9), issued by the German Competent Authority
EN
15 May 2009
Methodology and points to consider
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
EN
EN
EN
Adverse effects on human or animal health or on the environment are not expected.
EN
EN
EN
3 field sites in different regions of Germany; for details refer to German LMO/GMO location register (http://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?).
EN
PCR-based method, event-specific, submitted with a notification for placing on the market under Regulation (EU) Nr. 1829/2003, available at: http://gmo-crl.jrc.ec.europa.eu/StatusOfDossiers.aspx
EN
Additional information
-   deliberate release, no placing on the market
-   field trial, not for human consumption or for feed purposes

-  There is a Summary Notification Information Format available on the Internet (WebSNIF) for B/DE/08/198
EN
Records referencing this document Show in search
Record type Field Record(s)
Country's Decision or any other Communication Risk assessment 1